Sentien Biotechnologies, Inc. Announces $12 Million Series A Financing
Sentien Biotechnologies, Inc., a clinical-stage biotechnology company developing novel approaches to cell therapy, announced today that it has closed a $12 million Series A investment round. The [...]
